Deletion of STAT3 in the NK compartment drastically improved tumor rejection, immune surveillance, and IFN-γ secretion abilities, and targeting STAT3 with microRNA-130a augmented NK cytotoxicity against NSCLC cells [122,123]. The gene discussed is STAT3; the disease is non-small cell lung carcinoma.